Suppr超能文献

葡萄糖醛酸化在体外7-乙基-10-羟基喜树碱耐药中的作用。

The role of glucuronidation in 7-ethyl-10-hydroxycamptothecin resistance in vitro.

作者信息

Takahashi T, Fujiwara Y, Yamakido M, Katoh O, Watanabe H, Mackenzie P I

机构信息

Second Department of Internal Medicine, Hiroshima University School of Medicine.

出版信息

Jpn J Cancer Res. 1997 Dec;88(12):1211-7. doi: 10.1111/j.1349-7006.1997.tb00351.x.

Abstract

Although glucuronidation catalyzed by uridine 5'-diphosphoglucuronosyltransferase (UGT) is a major pathway of drug inactivation in humans, glucuronidation in malignant cells has received little attention as a cause of anti-cancer drug resistance. In this study, we tried to elucidate the role of SN-38 glucuronidation in the CPT-11-resistant human lung cancer cell line PC-7/CPT. PC-7/CPT cells possessed an increased activity to glucuronidate SN-38 compared to the parent cells, PC-7. Furthermore, sensitivity of PC-7/CPT cells to SN-38 was improved by inhibiting UGT activity. Western and northern blot analyses demonstrated that this increased activity was due to increased levels of UGT protein and mRNA. These results not only imply that upregulation of UGT activity in PC-7/CPT cells may contribute in part to SN-38 resistance, but also illustrate the important of drug metabolism within malignant cells themselves, as a cause of drug resistance.

摘要

尽管尿苷5'-二磷酸葡萄糖醛酸基转移酶(UGT)催化的葡萄糖醛酸化是人体药物失活的主要途径,但恶性细胞中的葡萄糖醛酸化作为抗癌药物耐药性的一个原因却很少受到关注。在本研究中,我们试图阐明SN-38葡萄糖醛酸化在CPT-11耐药的人肺癌细胞系PC-7/CPT中的作用。与亲本细胞PC-7相比,PC-7/CPT细胞具有更高的SN-38葡萄糖醛酸化活性。此外,抑制UGT活性可提高PC-7/CPT细胞对SN-38的敏感性。蛋白质免疫印迹和Northern印迹分析表明,这种活性增加是由于UGT蛋白和mRNA水平升高所致。这些结果不仅意味着PC-7/CPT细胞中UGT活性的上调可能部分导致了SN-38耐药性,还说明了恶性细胞自身内药物代谢作为耐药性原因的重要性。

相似文献

1
The role of glucuronidation in 7-ethyl-10-hydroxycamptothecin resistance in vitro.
Jpn J Cancer Res. 1997 Dec;88(12):1211-7. doi: 10.1111/j.1349-7006.1997.tb00351.x.
3
Chemosensitivity determinants of irinotecan hydrochloride in hepatocellular carcinoma cell lines.
Basic Clin Pharmacol Toxicol. 2008 Apr;102(4):399-407. doi: 10.1111/j.1742-7843.2007.00199.x. Epub 2008 Jan 30.
4
Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells.
Biochem Biophys Res Commun. 2001 Feb 9;280(5):1216-23. doi: 10.1006/bbrc.2001.4267.

引用本文的文献

1
Drug resistance mechanisms in cancers: Execution of pro-survival strategies.
J Biomed Res. 2024 Feb 28;38(2):95-121. doi: 10.7555/JBR.37.20230248.
2
Topoisomerase I poisons-induced autophagy: Cytoprotective, Cytotoxic or Non-protective.
Autophagy Rep. 2023;2(1):1-16. doi: 10.1080/27694127.2022.2155904. Epub 2022 Dec 25.
3
Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors.
Cancer Res. 2020 Oct 1;80(19):4258-4265. doi: 10.1158/0008-5472.CAN-20-1344. Epub 2020 Aug 24.
4
Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression.
Br J Cancer. 2020 Apr;122(9):1277-1287. doi: 10.1038/s41416-019-0722-0. Epub 2020 Feb 12.
5
Synergistic Effects of Simvastatin and Irinotecan against Colon Cancer Cells with or without Irinotecan Resistance.
Gastroenterol Res Pract. 2016;2016:7891374. doi: 10.1155/2016/7891374. Epub 2016 Feb 4.
6
New Topoisomerase I mutations are associated with resistance to camptothecin.
Mol Cancer. 2011 May 27;10:64. doi: 10.1186/1476-4598-10-64.
8
Role of ABCG2 as a biomarker for predicting resistance to CPT-11/SN-38 in lung cancer.
Cancer Sci. 2006 Mar;97(3):192-8. doi: 10.1111/j.1349-7006.2006.00164.x.
9
10
O(6)-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives.
Jpn J Cancer Res. 2002 Jan;93(1):93-102. doi: 10.1111/j.1349-7006.2002.tb01205.x.

本文引用的文献

1
Irinotecan (CPT-11) metabolites in human bile and urine.
Clin Cancer Res. 1996 Dec;2(12):1943-9.
4
No alteration in DNA topoisomerase I gene related to CPT-11 resistance in human lung cancer.
Jpn J Cancer Res. 1996 Dec;87(12):1280-7. doi: 10.1111/j.1349-7006.1996.tb03144.x.
5
Genetic diseases of bilirubin metabolism: the inherited unconjugated hyperbilirubinemias.
J Hepatol. 1996 Sep;25(3):398-404. doi: 10.1016/s0168-8278(96)80129-2.
7
Current perspectives on camptothecins in cancer treatment.
Br J Cancer. 1996 Aug;74(3):327-38. doi: 10.1038/bjc.1996.362.
10
Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome.
Lancet. 1996 Mar 2;347(9001):578-81. doi: 10.1016/s0140-6736(96)91273-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验